Aligos Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.77

+0.34 (+6.26%)

As of Jun 30, 10:41 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +7.3% upside

Low Target $4.22

Average Target $6.19

High Target $8.57

Current Price $5.77

Current
$5.77

Target
$6.19

$4.22 $6.19 avg $8.57

Scenario Analysis

Bear Case

$4.22

-26.9%

Low target

Base Case

$6.19

+7.3%

Avg target

Bull Case

$8.57

+48.5%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$13.69

-57.8% from high

52-Week Low

$4.80

+20.2% from low

Target vs 52W High

$6.19

-54.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%